Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
Abstract MicroRNA-371a-3p (miR371) has been suggested as a sensitive biomarker in testicular germ cell cancer (TGCC). We aimed to compare miR371 with the classical biomarkers α-fetoprotein (AFP) and β-human chorionic gonadotropin (hCGβ). Overall, 180 patients were prospectively enrolled in the study...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/007a32cb6b57433c9a8d6a521c3627cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:007a32cb6b57433c9a8d6a521c3627cb |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:007a32cb6b57433c9a8d6a521c3627cb2021-12-02T18:49:32ZSerum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study10.1038/s41598-021-94812-22045-2322https://doaj.org/article/007a32cb6b57433c9a8d6a521c3627cb2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94812-2https://doaj.org/toc/2045-2322Abstract MicroRNA-371a-3p (miR371) has been suggested as a sensitive biomarker in testicular germ cell cancer (TGCC). We aimed to compare miR371 with the classical biomarkers α-fetoprotein (AFP) and β-human chorionic gonadotropin (hCGβ). Overall, 180 patients were prospectively enrolled in the study, with serum samples collected before and after orchiectomy. We compared the use of digital droplet PCR (RT-ddPCR) with the quantitative PCR used by others for detection of miR371. The novel RT-ddPCR protocol showed high performance in detection of miR371 in serum samples. In the study cohort, miR371 was measured using RT-ddPCR. MiR371 detected CS1 of the seminoma and the non-seminoma sub-types with a sensitivity of 87% and 89%, respectively. The total sensitivity was 89%. After orchiectomy, miR371 levels declined in 154 of 159 TGCC cases. The ratio of miR371 pre- and post-orchiectomy was 20.5 in CS1 compared to 6.5 in systemic disease. AFP and hCGβ had sensitivities of 52% and 51% in the non-seminomas. MiR371 is a sensitive marker that performs better than the classical markers in all sub-types and clinical stages. Especially for the seminomas CS1, the high sensitivity of miR371 in detecting TGCC cells may have clinical implications.Mette Pernille MyklebustAnna ThorBenedikte RosenlundPeder GjengstøÁsa KarlsdottirMarianne BrydøyBogdan S. BerceaChristian OlsenIda JohnsonMathilde I. BergCarl W. LangbergKristine E. AndreassenAnders KjellmanHege S. HaugnesOlav DahlNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Mette Pernille Myklebust Anna Thor Benedikte Rosenlund Peder Gjengstø Ása Karlsdottir Marianne Brydøy Bogdan S. Bercea Christian Olsen Ida Johnson Mathilde I. Berg Carl W. Langberg Kristine E. Andreassen Anders Kjellman Hege S. Haugnes Olav Dahl Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study |
description |
Abstract MicroRNA-371a-3p (miR371) has been suggested as a sensitive biomarker in testicular germ cell cancer (TGCC). We aimed to compare miR371 with the classical biomarkers α-fetoprotein (AFP) and β-human chorionic gonadotropin (hCGβ). Overall, 180 patients were prospectively enrolled in the study, with serum samples collected before and after orchiectomy. We compared the use of digital droplet PCR (RT-ddPCR) with the quantitative PCR used by others for detection of miR371. The novel RT-ddPCR protocol showed high performance in detection of miR371 in serum samples. In the study cohort, miR371 was measured using RT-ddPCR. MiR371 detected CS1 of the seminoma and the non-seminoma sub-types with a sensitivity of 87% and 89%, respectively. The total sensitivity was 89%. After orchiectomy, miR371 levels declined in 154 of 159 TGCC cases. The ratio of miR371 pre- and post-orchiectomy was 20.5 in CS1 compared to 6.5 in systemic disease. AFP and hCGβ had sensitivities of 52% and 51% in the non-seminomas. MiR371 is a sensitive marker that performs better than the classical markers in all sub-types and clinical stages. Especially for the seminomas CS1, the high sensitivity of miR371 in detecting TGCC cells may have clinical implications. |
format |
article |
author |
Mette Pernille Myklebust Anna Thor Benedikte Rosenlund Peder Gjengstø Ása Karlsdottir Marianne Brydøy Bogdan S. Bercea Christian Olsen Ida Johnson Mathilde I. Berg Carl W. Langberg Kristine E. Andreassen Anders Kjellman Hege S. Haugnes Olav Dahl |
author_facet |
Mette Pernille Myklebust Anna Thor Benedikte Rosenlund Peder Gjengstø Ása Karlsdottir Marianne Brydøy Bogdan S. Bercea Christian Olsen Ida Johnson Mathilde I. Berg Carl W. Langberg Kristine E. Andreassen Anders Kjellman Hege S. Haugnes Olav Dahl |
author_sort |
Mette Pernille Myklebust |
title |
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study |
title_short |
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study |
title_full |
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study |
title_fullStr |
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study |
title_full_unstemmed |
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study |
title_sort |
serum mir371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet pcr in a prospective study |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/007a32cb6b57433c9a8d6a521c3627cb |
work_keys_str_mv |
AT mettepernillemyklebust serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT annathor serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT benedikterosenlund serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT pedergjengstø serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT asakarlsdottir serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT mariannebrydøy serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT bogdansbercea serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT christianolsen serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT idajohnson serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT mathildeiberg serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT carlwlangberg serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT kristineeandreassen serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT anderskjellman serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT hegeshaugnes serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy AT olavdahl serummir371intesticulargermcellcancerbeforeandafterorchiectomyassessedbydigitaldropletpcrinaprospectivestudy |
_version_ |
1718377542980730880 |